抑制外核苷酸酶增强自体T细胞对原代人结直肠癌球体的应答
在44例结直肠癌患者的前瞻性队列中,肿瘤浸润T细胞CD39表达升高并与PD-1共表达,且右半结肠和早期肿瘤中CD39表达更高。自体共培养模型显示CD39阻断可触发T细胞浸润并破坏肿瘤球体,提示CD39抑制是有前景的治疗策略。
要点
- 肿瘤浸润T细胞CD39表达升高,并与PD-1共表达。
- 右半结肠和早期肿瘤CD39表达更高,或界定对CD39阻断有应答的患者亚群。
- 自体共培养中CD39阻断触发T细胞浸润和肿瘤球体破坏。
核心结论
- 在结直肠癌中,CD39在肿瘤浸润淋巴细胞上强表达,其抑制是治疗患者的有前景策略。
研究设计与样本
- 前瞻性结直肠癌患者队列(n=44),研究肿瘤相关与非肿瘤相关肠道T细胞表型,尤其腺苷能通路,并与临床表型关联。
- 建立患者来源原发肿瘤球体与自体肿瘤相关淋巴细胞的自体共培养模型,用以评估CD39阻断对 antitumour T 细胞应答的影响。
主要发现
- 与黏膜淋巴细胞相比,肿瘤浸润T细胞上CD39表达增加,且CD39与PD-1共表达。
- CD39表达在右半结肠和早期肿瘤中更高,从而界定出可能对CD39阻断有应答的患者亚群。
- 在自体条件下,CD39阻断触发共培养中T细胞浸润和肿瘤球体破坏。
关键数值与推荐
- CD39表达在右半结肠和早期肿瘤中更高。
- CD39阻断在自体共培养中触发T细胞浸润和肿瘤球体破坏。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: T cells are major effectors of the antitumoural immune response. Their activation by tumour-associated antigens can unleash their proliferation and cytotoxic functions, leading to tumour cell elimination. However, tumour-related immunosuppressive mechanisms including the overexpression of immune checkpoints like programmed cell death protein-1 (PD-1), are also engaged, promoting immune escape. Current immunotherapies targeting these pathways have demonstrated weak efficacy in colorectal cancer (CRC). It is thus crucial to find new targets for immunotherapy in this cancer type. DESIGN: In a prospective cohort of patients with CRC, we investigated the phenotype of tumour-related and non-tumour related intestinal T cells (n=44), particularly the adenosinergic pathway, correlating with clinical phenotype. An autologous coculture model was developed between patient-derived primary tumour spheroids and their autologous tumour-associated lymphocytes. We used this relevant model to assess the effects of CD39 blockade on the antitumour T cell response. RESULTS: We show the increased expression of CD39, and its co-expression with PD-1, on tumour infiltrating T cells compared with mucosal lymphocytes. CD39 expression was higher in the right colon and early-stage tumours, thus defining a subset of patients potentially responsive to CD39 blockade. Finally, we demonstrate in autologous conditions that CD39 blockade triggers T cell infiltration and tumour spheroid destruction in cocultures. CONCLUSION: In CRC, CD39 is strongly expressed on tumour infiltrating lymphocytes and its inhibition represents a promising therapeutic strategy for treating patients.
引用
- Bonnereau J, Courau T, Asesio N, et al. Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition. Gut. 2022. PMID: 35803702. doi:10.1136/gutjnl-2021-326553
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。